Jason K Garland Repligen Corp (RGEN) insider trading activity

RGEN Quotes by TradingView

Jason K Garland is CFO of REPLIGEN CORP. Currently has a direct ownership of 7,676 shares of RGEN, which is worth approximately $1.09 Million. The most recent transaction as insider was on Nov 20, 2024, when has been sold 367 shares (Common Stock) at a price of $123.41 per share, resulting in proceeds of $45,291. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.68K
4.56% 3M change
39.49% 12M change
Total Value Held $1.09 Million

Jason K Garland Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2024
SELL
Payment of exercise price or tax liability
$45,291 $123.41 p/Share
367 Reduced 4.56%
7,676 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
2,540 Added 24.0%
8,043 Common Stock
Sep 25 2023
BUY
Grant, award, or other acquisition
-
5,503 Added 50.0%
5,503 Common Stock

Also insider at

ITGR
Integer Holdings Corp Healthcare
EVP, Chief Financial Officer
AFIB
Acutus Medical, Inc. Healthcare
Director
JKG

Jason K Garland

CFO
Carlsbad, CA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGEN